Apollo Hospitals Enterprise Ltd

Stage 3 · Topping · week 1

As of 9 Oct 2026, Apollo Hospitals Enterprise is in Stage 3 — topping, where an uptrend loses steam, in its first week (since 6 Oct 2026). It closed at ₹8,028, 11.5% below its 52-week high and below its 200-day average, which is rising. In Health Care, 44.6% of stocks are in Stage 2.

Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India. More about the company

₹8,027.5
+4.72% today
₹1.15L Cr · Large cap
Market Neutral — FadingHealth Care 44.6% in Stage 2-2.6 pts / 20dHospitals & Diagnostic Centres 32.3%-6.5 pts

Pro read

Pro

Our read

Topping — the uptrend is tiring

Setup score

—

Momentum

Steady

Edge

—

Is APOLLOHOSP early, or has it already run? Pro answers that for every NSE stock, after every close.

₹2,999 · 12 months₹1,999 · 6 months
Loading price chart…
vs 52W High
-11.5%
₹6,784.5 lo₹9,069 hi
11.5% below 52W high — weakening from peak
Stock is rolling over from its 52W high. Stage 3 distribution — new longs are high risk here.
Stage Maturity
Week 1
1w13w26w
Week 1 — early distribution
How long this stock has been in Stage 3 distribution. Longer tops often precede deeper Stage 4 declines.
vs 200 DMA
-0.2%
200 DMA: ₹8,040.9 · rising
Stock is losing its 200 DMA. Once lost, it confirms Stage 4 risk. This is a major red flag for existing holders.
Rel Volume
3.28x
vs 50-day avg
Volume spikes on down days during Stage 3 signal distribution — institutions are exiting. A clear warning to avoid new longs.
Trend Health
↓
MA20 rolling over · -3.2% vs MA50 -1.4%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
-9.2%
3M
-9.2%
6M
+8.5%
YTD
+13.6%
1Y
+8.0%
Sector
Health Care
↓ Peaking
Stage 2%
44.6%
20d Δ
-2.6pp
1M return
-4.9%
3M return
+0.2%
Sector Stage-2 % · last 20 days
Sector has 74 Stage 2 leaders. See Health Care Stage 2 →
Industry
Hospitals & Diagnostic Centres
↓ Peaking
Stage 2%
32.3%
20d Δ
-6.5pp
1M return
-8.1%
3M return
-10.8%
Industry Stage-2 % · last 20 days
Industry has 9 Stage 2 leaders. See Hospitals & Diagnostic Centres Stage 2 →
Stage Cycle Timeline2023-07-14 → 2026-10-09
S2 25w
S2 28w
S2 24w
S2 25w
2023-07-142026-10-09
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 7w → S3 9w → S2 25w → S3 11w → S2 28w → S3 5w → S4 8w → S1 5w → S2 24w → S3 7w → S4 7w → S1 6w → S2 25w → S3 1w current
Total tracked: 168 weeks across 14 stage runs.
Scan Membership
Breakout Watch
Latest: 2026-04-13
3 appearances in last 60 days. First seen: 2024-07-19.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-09S3
Wk 1 · Vol 3.28x
2026-10-08S3
Wk 1 · Vol 2.18x
2026-10-07S3
Wk 1 · Vol 1.30x
2026-10-06S32→3
Wk 1 · Vol 2.68x
2026-10-05S2
Wk 25 · Vol 2.32x
2026-10-01S2
Wk 25 · Vol 2.54x
2026-09-30S2
Wk 25 · Vol 6.34x
2026-09-29S2
Wk 24 · Vol 1.87x
2026-09-28S2
Wk 24 · Vol 1.34x
2026-09-25S2
Wk 24 · Vol 1.38x
2026-09-24S2
Wk 24 · Vol 1.20x
2026-09-23S2
Wk 24 · Vol 1.32x
Sector Peers — Stage 2All →
BAFNAPH
wk 18 · 0.0% from hi
8.6
ZIMLAB
wk 22 · 0.0% from hi
8.3
KILITCH
wk 2 · -7.3% from hi
8.3
SMSPHARMA
wk 3 · -8.0% from hi
8.3
RPGLIFE
wk 16 · -12.0% from hi
7.6
Moving averages & range
50 DMA
₹8,706.4
200 DMA
₹8,040.9
52W High
₹9,069
52W Low
₹6,784.5
5D Low
₹7,666
Resistance levels (recent highs)
20d High
₹9,069
60d High
₹9,069
120d High
₹9,069
250d High
₹9,069
Next resistance
+13.0%
to 20d High
Ask the Market AI about APOLLOHOSPAsk →
P/E (TTM)
61.1
Forward 38.7
Earnings Growth (YoY)
+35.6%
Revenue +18.1%
ROE
+21.5%
Profit margin +7.7%
Dividend Yield
0.24%
P/B 12.5
About this companyHealth Care· Hospitals & Diagnostic Centres

Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments. The company's healthcare facilities comprise primary, secondary, and tertiary care, as well as specialty facilities. It offers services in cardiac sciences, oncology, neurosciences, gastroenterology, orthopedics, urology, organ transplantation, pulmonology, obstetrics and gynecology, internal medicine, vascular surgery, pediatrics, cosmetology, emergency medicine, bariatric surgery, general surgery, colorectal surgery, dentistry, nephrology, dermatology, endocrinology, preventive medicine, interventional radiology, ophthalmology, and integrative medicine, as well as robotic surgery and genomics. The company also provides project consultancy, medical educational institutes, Medvarsity for e-learning, and research services, as well as acts as an agent for life, general, and health insurance. In addition, it operates hospitals, pharmacies, primary care clinics, and diagnostic centers; short stay facilities, boutique birthing centers, multi-specialty clinics, dental and dialysis facilities, and preventive care; day surgery, diabetes management, and cradle and fertility centers; and Apollo 24/7, a digital health mobile platform that provides teleconsultations, online pharmacy deliveries, home diagnostics, and insurance services. Further, the company engages in the business of bio-banking of tissues. It serves patients, corporate clients, and the government and public sectors. Apollo Hospitals Enterprise Limited was incorporated in 1979 and is based in Chennai, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-09. Past data patterns are not indicative of future results. This page is a data analytics tool only.